A Survey of The Combined Therapy of Isoflavonoids and Nifedipine, Atorvastatin or Captopril on Chronic Kidney Disease
碩士 === 國立彰化師範大學 === 生物技術研究所 === 101 === Patients with chronic kidney disease (CKD) are increasing. Interventions such as controlling hypertension and specific pharmacologic options are recommended. While some isoflavonoids may have benefits in this regard. We design this study into two parts. Part I...
Main Author: | 王詩儀 |
---|---|
Other Authors: | 謝秋蘭 |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/24571940777549066223 |
Similar Items
-
Nifedipine, captopril or sublingual nitroglycerin, which can reduce blood pressure the most?
by: Ali Maleki, et al.
Published: (2011-08-01) -
Effect of antihypertensive agents - captopril and nifedipine - on the functional properties of rat heart mitochondria
by: Ivana Kancirová, et al.
Published: (2016-06-01) -
Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
by: Maryam Paseban, et al.
Published: (2019-03-01) -
The potential of Atorvastatin for chronic lung diseases therapy
by: Alaa S. Tulbah
Published: (2020-11-01) -
Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension.
by: Zahra Sepehri, et al.
Published: (2016-01-01)